{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:57:43Z","timestamp":1781308663914,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128456","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:15:12Z","timestamp":1773256512000},"page":"128456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypoxia restricts the generation of BCG-responsive polycytotoxic T cells"],"prefix":"10.1016","volume":"79","author":[{"given":"Jean","family":"de Dieu Harelimana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zumwinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Mohnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Weper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Romahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Z\u00e4hnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Grieshober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2026.128456_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molimm.2015.08.004","article-title":"Hypoxia-inducible factors regulate T cell metabolism and function","volume":"68","author":"Phan","year":"2015","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128456_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010153","article-title":"Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients","volume":"13","author":"Nagy","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128456_bb0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/thoraxjnl-2015-207402","article-title":"Hypoxia and tissue destruction in pulmonary TB","volume":"71","author":"Belton","year":"2016","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128456_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Sig Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128456_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-024-01087-5","article-title":"How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia","volume":"25","author":"Mirchandani","year":"2025","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128456_bb0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/biomedicines9030260","article-title":"Hypoxia\/HIF modulates immune responses","volume":"9","author":"Chen","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128456_bb0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Sig Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128456_bb0040","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.4049\/jimmunol.1100976","article-title":"Hypoxia triggers the expression of human \u03b2 Defensin 2 and antimicrobial activity against mycobacterium tuberculosis in human macrophages","volume":"188","author":"Nickel","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128456_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00430-015-0442-x","article-title":"Hypoxia promotes mycobacterium tuberculosis-specific up-regulation of granulysin in human T cells","volume":"205","author":"Zenk","year":"2016","journal-title":"Med Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128456_bb0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","article-title":"An HIF-1\u03b1\/VEGF-A Axis in cytotoxic T cells regulates tumor progression","volume":"32","author":"Palazon","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128456_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic T lymphocytes: all roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128456_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","article-title":"An early history of T cell-mediated cytotoxicity","volume":"18","author":"Golstein","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128456_bb0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2017.10.004","article-title":"Granzyme B disrupts central metabolism and protein synthesis in Bacteria to promote an immune cell death program","volume":"171","author":"Dotiwala","year":"2017","journal-title":"Cell"},{"issue":"5386","key":"10.1016\/j.vaccine.2026.128456_bb0070","first-page":"121","article-title":"An antimicrobial activity of cytolytic T cells mediated by Granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science, New Series"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128456_bb0075","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.03.062","article-title":"Cytotoxic cells kill intracellular Bacteria through Granulysin-mediated delivery of Granzymes","volume":"157","author":"Walch","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128456_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1164\/rccm.201509-1746OC","article-title":"Lipoarabinomannan-responsive Polycytotoxic T cells are associated with protection in human tuberculosis","volume":"194","author":"Busch","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2026.128456_bb0085","series-title":"Infect Immun","article-title":"Polycytotoxic T cells mediate antimicrobial activity against intracellular mycobacterium tuberculosis","volume":"93(1)","author":"Zumwinkel","year":"2025"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128456_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188016","article-title":"Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli","volume":"135","author":"Dallmann-Sauer","year":"2025","journal-title":"J Clin Invest"},{"issue":"26","key":"10.1016\/j.vaccine.2026.128456_bb0095","doi-asserted-by":"crossref","first-page":"eaat7668","DOI":"10.1126\/sciimmunol.aat7668","article-title":"Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria","volume":"3","author":"Balin","year":"2018","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128456_bb0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4049\/jimmunol.1800840","article-title":"HBHA-induced Polycytotoxic CD4+ T lymphocytes are associated with the control of mycobacterium tuberculosis infection in humans","volume":"202","author":"Aerts","year":"2019","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128456_bb0105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241571","article-title":"Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8\u03b1+ lymphocytes","volume":"222","author":"Simonson","year":"2025","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128456_bb0110","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.4049\/jimmunol.177.8.5647","article-title":"Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response","volume":"177","author":"Murray","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128456_bb0115","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/infdis\/jit570","article-title":"Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants","volume":"209","author":"Lutwama","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128456_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/438463","article-title":"Induction of Granulysin and perforin Cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth","volume":"2011","author":"Semple","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128456_bb0125","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/s41467-024-49050-1","article-title":"Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to mycobacterium tuberculosis","volume":"15","author":"Dintwe","year":"2024","journal-title":"Nat Commun"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2026.128456_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1865-1682.2008.01058.x","article-title":"Evaluation of Granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. Bovis \u0394RD1","volume":"56","author":"Capinos Scherer","year":"2009","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2026.128456_bb0135","series-title":"PLoS Pathog","first-page":"e1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5(4)","author":"Chen","year":"2009"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128456_bb0140","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1128\/IAI.00624-07","article-title":"Impaired expression of perforin and Granulysin in CD8 + T cells at the site of infection in human chronic pulmonary tuberculosis","volume":"75","author":"Andersson","year":"2007","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128456_bb0145","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in Guinea pigs, rabbits, and nonhuman Primates","volume":"76","author":"Via","year":"2008","journal-title":"Infect Immun"},{"issue":"43","key":"10.1016\/j.vaccine.2026.128456_bb0150","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128456_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1399-0039.2008.01218.x","article-title":"Biology and clinical relevance of granulysin","volume":"73","author":"Krensky","year":"2009","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128456_bb0160","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.1200570","article-title":"15 kDa Granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity","volume":"188","author":"Clayberger","year":"2012","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128456_bb0165","article-title":"Stabilization of hypoxia-inducible factor promotes antimicrobial activity of human macrophages against mycobacterium tuberculosis","volume":"2","author":"Zenk","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128456_bb0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6606052","article-title":"Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer","volume":"104","author":"Imai","year":"2011","journal-title":"Br J Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:51:36Z","timestamp":1781308296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"alternative-id":["S0264410X26002641"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128456","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia restricts the generation of BCG-responsive polycytotoxic T cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128456"}}